Stockreport

Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements [Yahoo! Finance]

Theratechnologies Inc. - Common Shares  (THTX) 
PDF Total Revenue $19 million, representing +17% growth year over year FDA Approves Prior Approval Supplement (PAS) for EGRIFTA SV ® sBLA Latest from VAMOS study demons [Read more]